18 May 2013
Keywords: celltech, antibody, shows, promise, bowel, disease, mentioned
Article | 02 October 1995
As mentioned briefly in the Marketletter last week, Celltech's antitumor necrosis factor antibody, CDP 571, has shown promise in a Phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.